Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29548964 | 1.00 | HTR2A (0.35) | HTR2ANOTUMKDM1AGAASMN1; SMN2 | |
| SCHEMBL2353102 | 0.86 | HTR2A (0.39) | HTR2ANOTUMKDM1AGAASMN1; SMN2 | |
| SCHEMBL30695310 | 0.86 | HTR2A (0.39) | HTR2ANOTUMKDM1AGAASMN1; SMN2 | |
| SCHEMBL24862270 | 0.84 | PDK2 (0.37) | SMN1; SMN2ATMPDK2 | |
| SCHEMBL18656390 | 0.84 | RXRA (0.33) | NOTUMGAASMN1; SMN2 | |
| SCHEMBL16021623 | 0.84 | RXRA (0.33) | NOTUMGAASMN1; SMN2 | |
| SCHEMBL17055594 | 0.82 | PDK2 (0.37) | HTR2AKDM1AGAASMN1; SMN2PDK2 | |
| SCHEMBL18415542 | 0.82 | MAPT (0.39) | PDK2 | |
| SCHEMBL13712348 | 0.81 | PDK2 (0.42) | GAASMN1; SMN2ATMPDK2 | |
| SCHEMBL10626686 | 0.80 | KDM1A (0.45) | HTR2AKDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11530230-B2 | Compound of 3,3,3′,3′-tetramethyl-1,1′-spirobiindane-based phosphine ligand, and preparation method thereof | ZHEJIANG UNIVERSITY (CN) | 2022-12-20 | — | — | US | claimed |
| US-11377457-B2 | 3,3,3',3'-tetramethyl-1,1'-spirobiindane-based monophosphine ligand, intermediates thereof, preparation method and use of the same | ZHEJIANG UNIVERSITY (CN) | 2022-07-05 | — | — | US | claimed |
| CN-105229044-A | Sulfonyl-containing polymeric materials with rigid and contorted divinyl crosslinkers | 3M INNOVATIVE PROPERTIES CO | 2016-01-06 | — | — | CN | claimed |
| CN-104662054-A | Rigid and contorted divinyl crosslinkers | 3M INNOVATIVE PROPERTIES CO | 2015-05-27 | — | — | CN | claimed |
| EP-1660422-A2 | METHOD FOR MAKING SALTS OF HYDROXY-SUBSTITUTED HYDROCARBONS | GENERAL ELECTRIC COMPANY (US) | 2006-05-31 | — | — | EP | claimed |
| WO-2005021477-A2 | METHOD FOR MAKING SALTS OF HYDROXY-SUBSTITUTED HYDROCARBONS | GENERAL ELECTRIC COMPANY (US) | 2005-03-10 | — | — | WO | claimed |
| US-20250376552-A1 | RESIN COMPOSITION, CURED SUBSTANCE, LAMINATE, MANUFACTURING METHOD FOR CURED SUBSTANCE, MANUFACTURING METHOD FOR LAMINATE, MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE | FUJIFILM CORP (JP) | 2025-12-11 | — | — | US | disclosed |
| US-20250264801-A1 | RESIN COMPOSITION, CURED SUBSTANCE, LAMINATE, MANUFACTURING METHOD FOR CURED SUBSTANCE, MANUFACTURING METHOD FOR LAMINATE, MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE | FUJIFILM CORPORATION (JP) | 2025-08-21 | — | — | US | disclosed |
| EP-4596607-A1 | RESIN COMPOSITION, CURED OBJECT, LAYERED PRODUCT, METHOD FOR PRODUCING CURED OBJECT, METHOD FOR PRODUCING LAYERED PRODUCT, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE | FUJIFILM Corporation (JP) | 2025-08-06 | — | — | EP | disclosed |
| EP-4597225-A1 | FILM PRODUCTION METHOD, PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT PRODUCTION METHOD, CURED PRODUCT, AND LAMINATE | FUJIFILM Corporation (JP) | 2025-08-06 | — | — | EP | disclosed |
| EP-4596608-A1 | RESIN COMPOSITION, CURED PRODUCT, LAMINATE, METHOD FOR PRODUCING CURED PRODUCT, METHOD FOR PRODUCING LAMINATE, METHOD FOR PRODUCING SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE | FUJIFILM Corporation (JP) | 2025-08-06 | — | — | EP | disclosed |
| US-20250236697-A1 | RESIN COMPOSITION, CURED SUBSTANCE, LAMINATE, MANUFACTURING METHOD FOR CURED SUBSTANCE, MANUFACTURING METHOD FOR LAMINATE, MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE | FUJIFILM CORPORATION (JP) | 2025-07-24 | — | — | US | disclosed |
| US-20250230283-A1 | RESIN COMPOSITION, CURED SUBSTANCE, LAMINATE, MANUFACTURING METHOD FOR CURED SUBSTANCE, MANUFACTURING METHOD FOR LAMINATE, MANUFACTURING METHOD FOR SEMICONDUCTOR DEVICE, AND SEMICONDUCTOR DEVICE | FUJIFILM CORPORATION (JP) | 2025-07-17 | — | — | US | disclosed |
| US-20130164518-A1 | RESIN COMPOSITION FOR INJECTION COMPRISING LOW BIREFRINGENCE POLYMER BLEND, AND FRONT PANEL PREPARED USING THE SAME | LG HAUSYS, LTD. (KR) | 2013-06-27 | — | — | US | disclosed |
| EP-1497697-A2 | PHOTORESIST COMPOSITIONS COMPRISING ACETALS AND KETALS AS SOLVENTS | Clariant International Ltd. (CH) | 2005-01-19 | — | — | EP | disclosed |
| WO-2003085455-A2 | PHOTORESIST COMPOSITIONS COMPRISING ACETALS AND KETALS AS SOLVENTS | CLARIANT INTERNATIONAL LTD (CH) | 2003-10-16 | — | — | WO | disclosed |
| US-6203922-B1 | GLASSY THERMOPLASTIC RESINS WITH GLASS TRANSITION TEMPERATURE | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2001-03-20 | — | — | US | disclosed |
| US-6080522-A | CONTAINING PHOTORESIST AND POLYMER | CLARIANT INTERNAITONAL, LTD. (CH) | 2000-06-27 | — | — | US | disclosed |
| CN-1229480-A | Radiation-sensitive resist composition with high heat resistance | CLARIANT INT LTD (CH) | 1999-09-22 | — | — | CN | disclosed |
| EP-0922998-A1 | RADIATION-SENSITIVE RESIST COMPOSITION WITH HIGH HEAT RESISTANCE | Clariant International Ltd. (CH) | 1999-06-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11377457-B2 | 3,3,3',3'-tetramethyl-1,1'-spirobiindane-based monophosphine ligand, intermediates thereof, preparation method and use of the same | PHOSPHO1, TPI1, TPR | HTR2A 1427/4885NOTUM 1447/4885KDM1A 4585/4885 |
| US-11530230-B2 | Compound of 3,3,3′,3′-tetramethyl-1,1′-spirobiindane-based phosphine ligand, and preparation method thereof | ORMDL3, TALDO1, TAC3 | HTR2A 1074/4885NOTUM 903/4885KDM1A 4138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.